• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科肿瘤护理和临床试验中的伦理挑战。

Ethical Challenges in Pediatric Oncology Care and Clinical Trials.

机构信息

Division of Hematology-Oncology, Department of Pediatrics, Vanderbilt University Medical Center, 2220 Pierce Avenue 397 PRB, Nashville, TN, 37232-6310, USA.

Division of Pediatric Hematology/Oncology, Harvard Medical School, Center for Bioethics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, 02215, USA.

出版信息

Recent Results Cancer Res. 2021;218:149-173. doi: 10.1007/978-3-030-63749-1_11.

DOI:10.1007/978-3-030-63749-1_11
PMID:34019168
Abstract

The care of pediatric cancer patients is a vast departure from cancer care of adults. While the available treatment modalities-chemotherapy, radiation, and surgery-are the same, the diseases, care-delivery, and outcomes differ greatly. And just as 'children are not just little adults,' pediatric bioethics occupies a distinct place within the broader field of bioethics. In this chapter, we will begin with an introduction to fundamental principles and frameworks for understanding ethical issues in pediatrics, highlighting the triadic nature of medical decision-making between a physician, the child-patient, and the child's parent as the surrogate decision-maker. We will then delve into further details of how these principles and frameworks shape the care of children with cancer, examining specific ethical challenges commonly encountered by pediatric oncologists. We will traverse this landscape by examining issues involving (a) informed consent; (b) research involving children; (c) end of life; (d) genetic and genomic testing; and (e) professionalism. We also examine ethical challenges in clinical research, in children and more broadly. While not an exhaustive exploration of the myriad ethical issues one might encounter in pediatric cancer medicine and clinical trials, this chapter provides readers with a foundation for further reading.

摘要

儿科癌症患者的护理与成人癌症护理有很大的不同。虽然可用的治疗方法——化疗、放疗和手术——是相同的,但疾病、护理提供和结果却有很大的不同。正如“儿童不仅仅是小大人”一样,儿科生物伦理学在更广泛的生物伦理学领域中占据着独特的地位。在本章中,我们将首先介绍理解儿科伦理问题的基本原则和框架,强调医生、患儿和患儿的父母作为替代决策者之间的三方医学决策性质。然后,我们将深入探讨这些原则和框架如何塑造对癌症患儿的护理,检查儿科肿瘤学家通常遇到的具体伦理挑战。我们将通过研究涉及(a)知情同意;(b)涉及儿童的研究;(c)生命末期;(d)遗传和基因组测试;和(e)专业性的问题来探讨这个领域。我们还研究了儿童和更广泛范围内临床研究中的伦理挑战。虽然这不是对儿科癌症医学和临床试验中可能遇到的无数伦理问题的详尽探讨,但本章为读者提供了进一步阅读的基础。

相似文献

1
Ethical Challenges in Pediatric Oncology Care and Clinical Trials.儿科肿瘤护理和临床试验中的伦理挑战。
Recent Results Cancer Res. 2021;218:149-173. doi: 10.1007/978-3-030-63749-1_11.
2
Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences.儿科肿瘤临床护理与研究实践交叉点的伦理问题:对父母和医生经验的叙述性综述。
BMC Med Ethics. 2011 Sep 27;12:18. doi: 10.1186/1472-6939-12-18.
3
Ethics of Pediatric and Young Adult Medical Decision-Making: Case-Based Discussions Exploring Consent, Capacity, and Surrogate Decision-Making.儿科和青少年医疗决策的伦理:基于案例的讨论,探讨同意、能力和代理决策。
MedEdPORTAL. 2021 Feb 11;17:11094. doi: 10.15766/mep_2374-8265.11094.
4
Informed Consent in Decision-Making in Pediatric Practice.知情同意在儿科实践中的决策制定。
Pediatrics. 2016 Aug;138(2). doi: 10.1542/peds.2016-1485.
5
Ethical issues in pediatric life-threatening illness: dilemmas of consent, assent, and communication.儿童危及生命疾病中的伦理问题:同意、赞同与沟通的困境
Ethics Behav. 1997;7(1):43-57. doi: 10.1207/s15327019eb0701_4.
6
Decision making in pediatric oncology: Views of parents and physicians in two European countries.儿科肿瘤学中的决策制定:两个欧洲国家父母与医生的观点
AJOB Empir Bioeth. 2017 Jan-Mar;8(1):21-31. doi: 10.1080/23294515.2016.1234519. Epub 2016 Sep 22.
7
Informed Consent in Pediatric Oncology: A Systematic Review of Qualitative Literature.儿科肿瘤学中的知情同意:定性文献的系统评价
Cancer Control. 2018 Jan-Mar;25(1):1073274818773720. doi: 10.1177/1073274818773720.
8
Kids and cancer: ethical issues in treating the pediatric oncology patient.儿童与癌症:治疗儿科肿瘤患者的伦理问题
Cancer Treat Res. 2000;102:99-135. doi: 10.1007/978-1-4757-3044-9_9.
9
Valid informed consent and participative decision-making in children with cancer and their parents: a report of the SIOP Working Committee on psychosocial issues in pediatric oncology.癌症患儿及其父母的有效知情同意和参与式决策:国际小儿肿瘤学会(SIOP)儿科肿瘤心理社会问题工作委员会的报告
Med Pediatr Oncol. 2003 Apr;40(4):244-6. doi: 10.1002/mpo.10262.
10
Ethical issues in pediatric oncology phase I-II trials based on a mother's point of view.基于母亲视角的儿童肿瘤学I-II期试验中的伦理问题。
Bull Cancer. 2005 Nov;92(11):E57-60.

引用本文的文献

1
The state of targeted therapeutic pharmacological approaches in pediatric neurosurgery: report from the European Society for Pediatric Neurosurgery (ESPN) Consensus Conference 2024.小儿神经外科靶向治疗药理学方法的现状:来自欧洲小儿神经外科学会(ESPN)2024年共识会议的报告
Childs Nerv Syst. 2025 Apr 2;41(1):149. doi: 10.1007/s00381-025-06799-0.
2
The childhood cancer data initiative: enabling data sharing to drive research advances and transform pediatric cancer diagnosis and treatment.儿童癌症数据倡议:推动数据共享以促进研究进展并变革儿科癌症的诊断与治疗。
Curr Opin Pediatr. 2025 Feb 1;37(1):42-47. doi: 10.1097/MOP.0000000000001422. Epub 2024 Nov 27.
3

本文引用的文献

1
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.维莫非尼治疗儿童难治性多系统朗格汉斯细胞组织细胞增生症:一项国际观察性研究。
J Clin Oncol. 2019 Nov 1;37(31):2857-2865. doi: 10.1200/JCO.19.00456. Epub 2019 Sep 12.
2
Timing of first-in-child trials of FDA-approved oncology drugs.FDA 批准的肿瘤药物在儿童中首次进行临床试验的时机。
Eur J Cancer. 2019 May;112:49-56. doi: 10.1016/j.ejca.2019.02.011. Epub 2019 Mar 28.
3
Winning the RACE: Expanding pediatric cancer drug approvals.
Palliative care for children with central nervous system tumors: results of a Spanish multicenter study.
中枢神经系统肿瘤患儿的姑息治疗:一项西班牙多中心研究的结果。
Clin Transl Oncol. 2024 Mar;26(3):786-795. doi: 10.1007/s12094-023-03301-7. Epub 2023 Aug 30.
4
Managing Prognosis in Precision Medicine: Utility, Imagination, and Communication.精准医学中的预后管理:效用、想象力与沟通
Children (Basel). 2023 Mar 31;10(4):664. doi: 10.3390/children10040664.
赢得这场竞赛:扩大儿科癌症药物的批准范围。
Pediatr Blood Cancer. 2019 Aug;66(8):e27705. doi: 10.1002/pbc.27705. Epub 2019 Mar 11.
4
Therapeutic Misperceptions in Early-Phase Cancer Trials: From Categorical to Continuous.早期癌症试验中的治疗误解:从分类到连续
IRB. 2018 Jul-Aug;40(4):13-20. doi: 10.1002/eahr.406003.
5
Not All Disagreements Are Treatment Refusals: The Need for New Paradigms for Considering Parental Treatment Requests.并非所有分歧都是拒绝治疗:需要新的范式来考量父母的治疗请求。
Am J Bioeth. 2018 Aug;18(8):56-58. doi: 10.1080/15265161.2018.1485765.
6
Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.直接面向消费者的基因检测:美国食品药品监督管理局首次批准BRCA突变检测上市的影响
JAMA. 2018 Jun 19;319(23):2377-2378. doi: 10.1001/jama.2018.5330.
7
Communication About Prognosis With Adolescent and Young Adult Patients With Cancer: Information Needs, Prognostic Awareness, and Outcomes of Disclosure.与青少年和青年癌症患者沟通预后:信息需求、预后意识和披露结果。
J Clin Oncol. 2018 Jun 20;36(18):1861-1867. doi: 10.1200/JCO.2018.78.2128. Epub 2018 Apr 23.
8
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.拉罗替尼治疗携带 NTRK 基因融合的儿科实体瘤:多中心、开放标签、1 期/2 期研究的 1 期结果。
Lancet Oncol. 2018 May;19(5):705-714. doi: 10.1016/S1470-2045(18)30119-0. Epub 2018 Mar 29.
9
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.拉罗替尼在成人和儿童TRK融合阳性癌症中的疗效。
N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448.
10
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis.儿科肿瘤 I 期临床试验的风险和替代获益:系统评价和荟萃分析。
PLoS Med. 2018 Feb 20;15(2):e1002505. doi: 10.1371/journal.pmed.1002505. eCollection 2018 Feb.